Chimerix to Announce First Quarter 2019 Financial Results on May 9, 2019

DURHAM, N.C., May 02, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. CMRX, a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that it will host a live conference call and audio webcast on Thursday, May 9, 2019 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2019, and to provide a business overview.

To access the live conference call, please dial (877) 354-4056 (domestic) or (678) 809-1043 (international) at least five minutes prior to the start time, and refer to conference ID 3891009. A live audio webcast of the call will also be available on the Investors' section of the Company's website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.

About Chimerix

Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients. Brincidofovir (BCV, CMX001) uses Chimerix's proprietary lipid conjugate technology. For further information, please visit Chimerix's website, www.chimerix.com.

CONTACT:

Investor Relations:

Michelle LaSpaluto

919-972-7115 

ir@chimerix.com

or

Will O'Connor

Stern Investor Relations 

Will@sternir.com

212-362-1200

Media:

Becky Vonsiatsky

W2O Group 

bvonsiatsky@w2ogroup.com 

413-478-2003